{"id":"W4401410496","doi":"10.1159/000540290","title":"Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma","year":2024,"lang":"en","type":"article","venue":"Liver Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sudbury Regional Hospital","funders":"National Cancer Institute; University of California, San Francisco; University of Texas MD Anderson Cancer Center; Puma Biotechnology; Memorial Sloan-Kettering Cancer Center","keywords":"Neratinib; Medicine; Sunitinib; Everolimus; Axitinib; Tyrosine-kinase inhibitor; Nivolumab; Pembrolizumab; Internal medicine; Clinical endpoint; Oncology; Cancer; Immunotherapy; Clinical trial; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001874221,0.0003313065,0.000399696,0.0001809046,0.00003572641,0.00003785462,0.0001651448,0.0001783903,0.0001077844],"category_scores_gemma":[0.00001583065,0.0002125678,0.00004802055,0.0005704858,0.0001685002,0.00003162707,0.00006098829,0.0002418068,0.000002067366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001798742,"about_ca_system_score_gemma":0.0005852869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009985995,"about_ca_topic_score_gemma":0.002914813,"domain_scores_codex":[0.9981284,0.00008827449,0.0004648513,0.0005878172,0.0003769729,0.0003536859],"domain_scores_gemma":[0.9992307,0.00001998004,0.0001849153,0.0003299739,0.0001589634,0.00007540746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009629192,0.0003281342,0.9244326,0.0004787717,0.0001660857,0.00009325593,0.001373848,0.001467045,0.0602423,0.000007485384,0.0004049185,0.001376373],"study_design_scores_gemma":[0.01001517,0.006575644,0.1805699,0.001801432,0.00008401485,0.00001306491,0.0002979772,0.0006178651,0.7967381,0.000005542595,0.002514608,0.0007667459],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967583,0.001947418,0.0001128389,0.0000963175,0.0001981341,0.0007225426,0.00006028619,0.0000192751,0.00008486444],"genre_scores_gemma":[0.9975799,0.00006890468,0.001240334,0.00006960653,0.00014739,0.0001660827,0.0001298509,0.00008091691,0.0005169643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7438627,"threshold_uncertainty_score":0.8668265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007036782436839323,"score_gpt":0.2275670107357827,"score_spread":0.2205302282989434,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}